Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
SP Industries CEO Brian Larkin has announced the signing of a partnership agreement with Ecodyst.
read more
Wednesday, December 05, 2018
Contract development and manufacturing organisation (CDMO) Idifarma has confirmed it is ready to meet forthcoming EU serialisation regulations.
read more
Thursday, February 06, 2020
Spaulding Clinical Research has named Cassandra Erato chief executive officer, effective February 1, 2020.
read more
Spaulding Clinical, a leading clinical research organization (CRO), is expanding its services to include ADME (absorption, distribution, metabolism, and excretion) clinical trials.
read more
Spaulding Clinical, a full-service Phase I clinical service provider, announced expanded services for clinical trial Phases I through III, including biometrics, data management, and medical writing. While approaching their 15th anniversary and ...
read more
Thursday, February 27, 2020
Spaulding Clinical Research has been awarded a five-year contract with the FDA Division of Applied Regulatory Science to conduct multiple clinical trials in various therapeutic areas of interest.
read more
Quanticate has completed an investment initiative to upgrade its pharmacovigilance safety database and its in-house technology platform.
read more
Leading specialist development pharma, Amzell B.V, has signed a license and development agreement with Amring Pharmaceuticals Inc., a subsidiary of SEVER Life Sciences B.V., for the commercial rights to one of its leading clinical-stage candidates.
read more
SpectronRx announced the NRC has issued a Materials License for its new Indianapolis, IN headquarters.
read more
Spectrum Pharmaceuticals announced an exclusive licensing agreement with The University of Texas MD Anderson Cancer Center for intellectual property related to certain methods of use of poziotinib.
read more
Spheryx announced the NIH has awarded the company a Phase II SBIR grant to support the modification of their proprietary Total Holographic Characterization technology.
read more
Thursday, December 17, 2015
SPI Pharma, Inc., a fully owned subsidiary of Associated British Foods, and the Functional Additives Division of Asahi Kasei Chemicals have agreed to form an alliance in the field of pharmaceutical additives.
read more
Wednesday, August 04, 2021
SPI Pharma, a leading supplier of solutions to pharmaceutical formulation marketers is pleased to announce a new, exclusive agreement with Azelis Americas, a leading innovation service provider in the specialty chemicals and food ingredients industry...
read more
Tuesday, February 03, 2026
Spruce Biosciences announced the appointments of Daven Mody, Pharm.D., as Senior Vice President of Regulatory and Quality and Bruno Gagnon, B.Pharm., M.Sc., as Senior Vice President, Clinical Development Operations.
read more
SPT Labtech announced an initiative with Thermo Fisher Scientific to co-market solutions that will enable variant detection at a fraction of the cost.
read more